Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.
Yanada
Masamitsu
M
Huang
Xuelin
X
Garcia-Manero
Guillermo
G
O'brien
Susan
S
Ravandi
Farhad
F
Borthakur
Gautam
G
Faderl
Stefan
S
Issa
Jean-Pierre
JP
Kantarjian
Hagop
H
Estey
Elihu
E
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality; D016016:Proportional Hazards Models; D012074:Remission Induction; D015996:Survival Rate
D000970:Antineoplastic Agents